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1 Abbreviations used in this paper: C, core; E, envelope; FCS, fetal calf serum; FeLV, feline leukemia virus; FLV, Friend leukemia virus; FOCMA, feline oncornavirus-associated cell membrane antigen; GCSA, Gross cell surface antigen; GLV, Gross leukemia virus; gp, glycoprotein; KiSV, Kirsten sarcoma virus; LLV, lymphatic leukemia virus; LMC, lymphocyte-mediated cytolysis; LU, lytic unit; MCSA, Moloney cell surface antigen; Mo-MuLV, Moloney leukemia virus; MSV, murine sarcoma virus; MTLC, mixed tumor-lymphocyte culture; MuLV, murine leukemia virus; p, protein; PFU, plaque-forming units; RIA, radioimmunoassay; RLV, Rauscher leukemia virus; RT, reverse transcriptase; SFFV, spleen focus-forming virus; TASA, tumorassociated cell surface antigen. B C1-4 SFFV nonproducer cells biweekly for a period of 6 wk. Spleen and inguinal lymph node cells were used as responding lymphocytes in in vitro activation with 1902 B C1-4 cells, 2-12 wk after completion of the immunization schedule.
Viral Characterization of Target Cells.
Tests for RT activity (14) present in target cell tissue culture medium, and for production of mature MuLV (XC assay; 15) were conducted as previously described. As a more sensitive indicator of MuLV production in XC assays, 1 × 104 target cells were olden co-cultivated with SC-1 cells for 4 days before the addition of the XC rat indicator cell. Target cells used in LMC assays were tested for the presence of cell surface viral proteins in antibody-dependent, complement-mediated cytolysis assays. Heat-inactivated, absorbed, monospecific goat antisera raised against purified murine ecotropic and xenotrepic viral proteins were tested (obtained from Dr. Jack Gruber, Office of Program Resources and Logistics, Viral Oncology, National Cancer Institute). The antigenic specificity of all antisera used in these tests as defined by Dr. Gruber is detailed in Table I . Methods involved in antibody-dependent complement-mediated cytolysis assays have been previously described (10) .
7-day assays for MSV production on SC-1 mouse fibroblasts, using target tissue culture supernates were conducted as previously described (16) . Target cell tissue culture fluid was also Ion exchange chromatography GLVp30
Ion exchange chromatography RLV pl0
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Guanidine HC1 + agarose chromatography RLV pl5
Guanidine HC1 + agarose chromatography RLV p30
Guanidine HC1 + agarose chromatography RLV p60 pre-Guanidine HC1 + agacursor rose chromatography RLVgp69/71
Ion exchange chromatography ND, not done.
tested for xenotropic virus production on mink lung fibroblast cells as measured by insipient RT activity (17) . ATS-Dog and NZB-Dog cell tissue culture fluid was used as a positive control in all assays for xenotropic virus production (cells obtained from Dr. Sandra K. Ruscetti, Laboratory of Tumor Virus Genetics, National Cancer Institute). 24-h tissue culture fluid harvested from cultures of SFFV nonpreducer and nonpreducer-rescued cell lines were assayed for in vivo SFFV activity by inoculation into CDF1 newborn mice. Assays for in vivo SFFV activity (18) were conducted by Dr. Richard Steeves.
In Vitro Activation of 1902 B Cl-4-Immune Lymphocytes. Spleen and inguinal lymph node
cells from immunized mice were teased apart from the intact organ with forceps, minced, and passed through successively smaller gauge needles to insure single cell suspension. Erythrocytes were removed from the cell population by hyposmotic shock, and the remaining cells were counted with a Coulter electronic counter (Coulter Electronics Inc., Hialeah, Fla.). A£cer we determined cell viability via trypan blue exclusion, we diluted cells in Click's medium (Altick Associates, Hudson, Wis.), supplemented with 2% FCS, 300 ~g/ml fresh L-glutamine, 50 U/ml penicillin, 50 ~g/ml gentamicin, 16 ~mol/ml NaHCO3, and 25 ~mol/ml Hepes buffer (Calbiochem, San Diego, Calif.). Spleen cell populations were adjusted to a final concentration of 2.5 x l0 s cells/ml. In vitro activation of 1902 B C1-4 immune lymphocytes was conducted by mixing 10 ml of spleen cells with 10 ml of UV-irradiated (6,000 electroretinograms/mm =) 1902 B C1-4 flbroblasts which had been adjusted in supplemented Click's medium to a concentration of 1.25 x l0 s cells/ml. In vitro lymphocyte activations were conducted in 30-ml tissue culture flasks (3012; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) cultured upright in a humidified atmosphere of 5% CO2 in air at 37°C. Activated lymphocytes were harvested after 5 days in culture, and viable cells were used as effector cells in LMC assays.
LMC Assays. 4 -h 5~Cr-release assays were conducted in 96-well V-bottom microplates (1S-MVC-96 TC; Linbro Chemical Company, New Haven, Conn.) using a methodology previously described (10) . Percent specific lysis was determined by using the following equation:
experimental cpm -medium control cpm percent specific lysis = 100 x maximum release cpm -medium control cpm" One lytic unit (LU) was defined as the number of effector cells required to cause 30% specific lysis. Data is displayed both graphically and in tabular form as percent cytotoxicity observed at an effector/target cell ratio of 100/1, and as LU/25 x 108 effector cells. In cases where 30% specific lysis was not achieved even at a relatively high effector/target cell ratio, LU were determined by graphical interpolation.
Results
Target Cell Viral Genome Expression. The virological characterization of all target cells used in these studies is displayed in Tables II and III [I Expressed in terms of RT activity of mink lung fibroblasts after 7-day culture in the presence of target cell tissue culture supernate. ¶ TNC, too numerous to count. ** nd, not done. surface of SFFV nonproducer cells which w,as capable of provoking meaningful cell-mediated immune reactivity. The fact that BALB/c 3T3 F-MuLV fibroblasts were not lysed by 1902 B C1-4 immune lymphocytes suggested that this cell surface antigen was not coded for by the helper virus genome. This suggestion was confirmed by results of subsequent experimentation displayed in Fig. 1 B. 1902 B C1-4-Mo-MuLV and 1902 B C1-4-R-MuLV SFFV-rescued targets were effectively lysed by SFFV nonproducer-immune activated lymphocytes. However, BALB/c 3T3 cells productively infected with either R-MuLV or Mo-MuLV remained unaffected. Therefore, the lysis of the SFFV-rescued cell lines was not due to cytotoxic reactivity directed against an LLV-coded cell surface antigen. The data displayed in Fig. 1 along with the observation that the SFFV nonproducer cells lacked cell surface expression of type-, group-, or interspeciesspecific viral structural antigens, indicated that the antigen detected by LMC was coded for solely by the SFFV genome.
It is interesting to note that both MCDV-12 (an RLV-induced leukemia cell) IA IB IO0- displayed in Table IV 
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Discussion
The results of these studies indicate that the SFFV genome codes for a cell surface antigen which is capable of provoking an antigen-specific cell-mediated immune response. The antigen was detected on the surface of cloned BALB/c 3T3 and FRE fibroblasts which contained the SFFV genome, free of replicating LLV. The SFFV nonproducer fibroblasts were void of cell surface expression of viral structural proteins as determined in antibody-dependent complement-mediated cytolysis assays using monospecific antisera raised against purified murine ecotropic and xenotropic structural polypeptides. Normal BALB/c 3T3 fibroblasts and BALB/c 3T3 cells infected with three types of helper LLV were not susceptible to lysis by SFFV nonproducer-immune lymphocytes. Based upon these observations, it is reasonable to assume that the antigen detected in these LMC experiments is not coded for by genetic information contained in the helper component of FLV and represents a true SFFV-specific cell surface antigen.
Several nonproducer-specific antigens have been investigated in experimental sarcoma and leukemia virus systems. However, most reported nonproducer TASAs have been confirmed serologically. The existence of such humorally defined TASAs remains a controversial subject, due to reports claiming that the antigens detected are simply viral structural proteins present at the cell surface.
Cats infected with feline leukemia virus (FeLV) contain in their sera antibodies specific for an antigen present on the surface of FeLV-transformed cat cells (19) . Antisera harvested from FeLV-infected cats retains its specificity and affinity for the feline leukemia cell surface, even aider absorption with FeLV structural proteins gp70 and p30 (20) . Furthermore, humoral reactivity against this serologically detected feline-oncornavirus-associated cell membrane antigen (FOCMA) has been shown to positively correlate with the natural resistance of cats to FeLV-induced leukemia or sarcoma (21) . Data intimating that FOCMA expression may be the result of sarcoma virus genetic sequences was reported in studies detailing FOCMA cell surface expression on replicationdefective FeLV-transformed mink cells (22) . Whether or not FOCMA truly represents a cell surface neoantigen distinct from virion structural proteins remains open to question. Recently, Ruscetti and Parks (23), using immune precipitation of radiolabeled cell membranes and polyacrylamide gel electrophoresis presented evidence indicating that anti-FOCMA immune reactivity may indeed be directed against a class of 85,000 mol wt proteins which contain determinants of the major FeLV glycoprotein.
A similar antigen present on the surface of cells transformed by Gross leukemia virus (GLV) has also been recently characterized. Antibody directed against the Gross cell surface antigen (GCSA) has been traditionally prepared by immunization of C57B1/6 mice with the transplanted AKR spontaneous leukemia (K-36) (24) . Anti-GCSA antibody has been found to be cytotoxic against cells infected with GLV and absorbed by the normal lymphoid tissues of mice with high incidences of spontaneous leukemia (24, 25) . Investigators using immunoelectron microscopy have determined that anti-GCSA antisera does not bind to portions of GLV-transformed lymphoma cell membranes that are associated with budding virions (26) . This observation prompted the suggestion that GCSA was not a structural component of GLV. However, two groups have simultaneously reported (in radioimmunoprecipitation studies) that the GCSA complex is actually composed of glycosylated precursors of MuLV core proteins which contain antigenic determinants specific for p30, p12, and pl0 (27, 28) .
In the Mo-MuLV system, a similar nonvirion TASA has been detected (Moloney cell-surface antigen; MCSA) using sera of syngeneic mice immunized with irradiated virus-producing lymphoma cells (29) . Mouse anti-MCSA serum has been found to contain virus-neutralizing antibodies which represent reactivity against gp71, the major envelope glycoprotein. However, virus-neutralizing activity could be removed by absorption either with cells which expressed surface concentrations of gp71 or with intact Mo-MuLV. This treatment had little effect on the antisera's cytotoxicity directed against lymphoma cells (30) . Recently, MCSA activity (tool wt 110,000) has been physically separated from Mo-MuLV structural proteins by concanavalin A affinity chromatography, gel filtration, and velocity centrifugation (30) . These results suggest that lVICSA indeed represents a neoantigen separate from virion structural proteins. An approach employing virus-transformed nonproducer tumor cells, similar to that used in the present studies, would lend further evidence in support of this interpretation.
Greenberger et al. (31) have demonstrated (using immunoelectron microscopy) a nonvirion TASA expressed on the surface of nonproducer K-BALB cells which could not be detected on the parent BALB/c 3T3 cell line. Because administration of this K-BALB antigen-specific antisera to normal mice did not protect against subsequent tumor challenge, these investigators concluded that the neoantigen present on the K-BALB cell did not function as a tumor-specific transplantation antigen. Recently, we reported the detection of a similar nonvirion K-BALB-specific antigen using the techniques of secondary and tertiary MTLC followed by LMC. Transfer of in vitro activated lymphocytes along with a lethal challenge of K-BALB cells to normal BALB/c mice mediated almost complete protection against subsequent K-BALB tumor development (32) . These findings suggest that a nonvirion antigen present on K-BALB cells does function as a TSTA. Whether or not this antigen is coded for by the replication-defective portion of the KiSV genome has not been established. However, this TSTA is not present on parent BALB/c 3T3 cells as detected by LMC (K. A. Smith, IV[. M. Ferm, S. Gillis, and A. E. Gillis, unpublished observations).
A common cell surface antigen (FMR) has been described on leukemia cells induced in vivo by FLV, RLV, and Mo-MuLV. Initial studies reporting crossreactivity between all three virally-induced leukemias have recently been questioned by results showing that cells induced by Mo-MuLV were antigenically distinct from those induced by FLV and RLV (33) . These data imply that such a serologically detected antigen common only to Friend and Rauscher leukemias may have determinants coded for by the SFFV genome. Regardless of the cross-reactivity of antigenic determinants detected by anti-FMR antisera, the nonvirion nature of these determinants has not been thoroughly established. It has been shown that anti-FLV antisera remain cytotoxic against FLVtransformed spleen cells despite exhaustive absorption with purified FLV (34) . However, the demonstration that the cytotoxic reactivity of anti-FMR antisera could be removed by absorption with disrupted virus suggests that FMR antibody reactivity may be directed against internal virion proteins (6). Despite these results, the observation that SFFV-immune lymphocytes mediated the lysis of FLV and RLV transformed leukemia cells suggests that some portion of classically defined FMR antigenic determinants may be ceded for by SFFV gene sequences.
The SFFV genome as it exists in the fibroblast nonproducer target cells studied in these investigations has recently been analyzed by molecular hybridization. The genome appears to be a recombinant between a portion of the F-MuLV genome and RNA sequences that are highly related (hybridizable) to three separate strains of murine xenotropic virus (11) . Further investigation has confirmed that the recombinational event between ecotropic and xenotropic virus sequences (responsible for the elaboration of SFFV genome) occurred somewhere in the envelope region of the xenotropic viral genome (35) . It is plausible that the specific cell surface antigen described in this report might be coded for by the xenotropic viral information contained within the SFFV genome. It would appear unlikely that the ecotropic sequences of the SFFV genome were responsible for coding for the SFFV antigen, in that BALB/c 3T3 cells productively infected with three types of ecotropic helper virus were not susceptible to lysis by SFFV nonproducer-immune lymphocytes.
Recently, Bernstein et al. (8) in radioimmunoassay (RIA) studies of SFFVcontaining murine and rat fibroblasts has determined that SFFV nonproducers contain high levels of cytosol p15, whereas the remaining gag-gene coded core proteins and the envelope glycoprotein gp71 were not present in detectable concentrations. Similar RIA studies of the SFFV nonproducer cells used in this report confirmed the cytosol presence of both p15 and p12 (D. H. Troxler, personal communication). These results intimate that the portion of ecotropic virus which remains complexed with the xenotropic sequences of SFFV RNA represent early gag-gene regions.
It is important to note that the 15,000 mol wt protein detected in the abovementioned RIA studies was not further characterized as the core (C) polypeptide p(15)C or the envelope (E) polypeptide p(15)E. The localization of a 15,000 mol wt protein [p(15)E] on the surface on intact C-type virus particles was originally described in neutralization experiments using anti-p(15)E antisera (36) . Furthermore, p(15)E has been isolated from virus-infected cells in stable association with gp71 as a common polypeptide precursor (37) . Although specific chemical differences between p(15)E and p(15)C have not been detailed, the antigenic characteristics of both molecules have been described, p(15)E appears to carry antigenic determinants with strong interspecies specificity as observed by the neutralization of FeLV and several murine xenotropic viruses by anti-FLVp(15)E antisera (38) . This observation is especially intriguing in light of the recently defined genetic composition of the SFFV genome as a recombination of ecotropic sequences into the envelope region of xenotropic MuLV.
Although one cannot rule out the possibility that the antigen described in these studies is a gag-gene-coded polypeptide, the observation that the p15 and p12 positive K°BALB R-MuLV target cell (Table III) was not lysed by 1902 B C1-4-immune spleen cells (Table IV) further supports the nonvirion SFFVo specific nature of the antigen detected. It is possible, however, that the antibody-dependent, complement-mediated cytolysis assay used in virological characterizations was not sensitive enough to detect extremely small cell surface concentrations of viral structural proteins. Perhaps an isotopic antiglobulin binding assay such as that described by Ruscetti and Parks (23) would be a more sensitive indicator of cell surface virion protein expression. Similarly, the use of radiolabeled target cell membranes in radioimmunoprecipitation competitive RIA studies might provide the most accurate means of determining the cell surface viral antigen expression of SFFV nonproducer cells.
Several analogies have been consistently drawn between the MSV and SFFV genome. Both are replication-defective and require rescue by tropic LLV. Both genomes are accepted as being responsible for the malignant transformation event in vivo. Studies conducted in this report (Table IV) indicate that a cell surface antigen coded expressly by SFFV genetic information is not shared by MSV-transformed fibroblasts, regardless of their capacity to produce infectious transforming virus. The lack of cross-reactive antigenicity in MSV and SFFV nonproducer cells is an observation which is understandable in light of recent hybridization investigations, indicating that little if any genetic information is common to both SFFV and MSV genomes. However, the detection of cell surface antigens by LMC on KiSV and SFFV replication-defective nonproducer cells suggests that nonvirion cell surface antigens may be coded for by genetic information intimately associated with those genes responsible for malignant transformation.
Summary
The existence of a nonvirion tumor-associated cell surface antigen (TASA) on cells transformed with Friend (FLV) on Rauscher (RLV) leukemia virus has been difficult to demonstrate. Antisera raised against classically defined FriendMoloney-Rauscher antigenic determinants have been shown to react with virus structural proteins coded for by genetic information contained in the lymphatic leukemia or helper (LLV) virus genome. The recent development of nontransformed fibroblast cell lines which contain the replication-defective spleen focusforming virus (SFFV) genome, free of replicating LLV, has allowed investigation of an SFFV-specific antigen. We have applied the techniques of mixed tumor-lymphocyte culture stimulation followed by lymphocyte-mediated cytolysis assays to search for the cell surface expression of an antigen coded expressly by SFFV genetic information.
SFFV nonproducer-immune, in vitro activated spleen cells were capable of effecting the lysis of SFFV-containing BALB/c 3T3 and Fischer rat epithelial, cloned cell lines. Normal BALB/c 3T3 and BALB/c 3T3 cells infected with three types of ecotropic LLV were unaffected. Syngeneic FLV and RLV-induced murine leukemia cells were also killed by SFFV nonproducer-immune lymphocytes. In addition, Kirsten sarcoma virus-transformed, replication-defective and replication-rescued BALB/c 3T3 fibroblasts were not susceptible to SFFV antigen-directed cytolysis. Antibody-dependent complement-mediated cytolysis assays using monospecific goat antisera confirmed that SFFV nonproducers lacked cell surface expression of virion structural proteins.
These observations suggest that the antigen detected in LMC experiments was not coded for by genetic information contained in the helper component of FLV, and that it represents a true SFFV-specific cell surface antigen. Based upon the recent molecular evaluation of the SFFV genome as consisting of both xenotropic and ecotropic virus sequences, it appears reasonable that xenotropic genetic information may be responsible for expression of the SFFV-specific antigen. Since the replication-defective SFFV genome is also responsible for the malignant transformation associated with FLV-induced erythroleukemia, one might postulate that gene sequences capable of programming transformation may also code for the TASA detected in these studies.
